🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

IVI launches a new initiative with Int. Centre for Antimicrobial Resistance Solutions, aimed to advance vaccine uptake to mitigate AMR in LMICs of South or South-East Asia. The project is led by Ateneo de Manila University and IQVIA Solutions Philippines. An important step in addressing AMR. 🔗ivi.int/ivi-and-icars-…

Cholera threatens over 1 billion people worldwide, especially in vulnerable communities. 🌍 A low-cost oral cholera vaccine is helping protect those most at risk. 📽️ Watch the full story about how IVI and partners made it happen 👉youtube.com/watch?v=EgtF2E…

Impact. Progress. Purpose. IVI’s 2024 Annual Report captures a year of expanding vaccine access, collaborative partnerships, and bold steps toward new life-saving vaccines. 🌍💉 🔗 ivi.int/ivi-annual-rep…

We’re proud to celebrate Dr. Nicaise Ndembi (Ndembi), Deputy Director General of IVI Africa, named to the #TIME100Health list. From leading Africa’s mpox response to advancing vaccine R&D at IVI, his impact is continent-wide. 🔗 time.com/collections/ti…

A strategic week at IVI comes to a close: our Board, Global Council, and Global Advisory Group of Experts met in Seoul to shape IVI’s future. The convergence of these leadership bodies underscores IVI’s role as a center of vaccine innovation and equitable access.

Welcoming applications for the next Hands-On Training offered through the Global Training Hub for Biomanufacturing! Gain practical experience in industrial facilities. Collaborate with global biomanufacturers. Network with peers. Learn more and apply by 5 June 2025 ⤵️

Thank you Ambassador Nkubito, Rwanda’s Ambassador to Korea, for the warm welcome and continued support. IVI looks forward to deepening our partnership.

🔬 It’s #WorldVaccineDay! Around the world, offices are opening their doors to show how vaccines are made - and why they matter. At IVI, we’re taking you behind the scenes with a virtual tour of our labs. 💉🌍 🎥 Watch now: youtube.com/watch?v=hRqQQ2…

It was great to meet with Ambassador Eric Teo at the Embassy of Singapore in Seoul. We discussed possible avenues for joint research and development in global health, and we are excited to deepen the partnership between International Vaccine Institute (IVI) and Singapore.

Thank you, Ambassador Prof.Emmy Kipsoi , Kenya’s Ambassador to Korea, for the warm welcome. IVI looks forward to building on our strong partnership and continued collaboration in vaccine research, development, and manufacturing.

Join us next week at #WHA78 in Geneva for a key event on leptospirosis—a neglected disease impacting vulnerable communities and worsened by climate change. 📅 May 20 | 🕑 2–3:30 p.m. CEST 📍 Warwick Geneva Hotel 🔗 ivi.int/join-us-on-the…

We were honored to welcome Dr. Youngmee Jee, Commissioner of Korea Disease Control and Prevention Agency and her team, to the IVI Europe Office in Stockholm on May 16. Thank you, Dr. Jee, for your support in advancing safe, affordable vaccines and global health security.

Excited to announce Hyerim Woo and her son Siwoo Shin have become IVI Goodwill Ambassadors! With their positive influence, we hope their involvement sparks public engagement in IVI’s mission of developing vaccines for global health. Learn more: ivi.int/hyerim-woo-and…

“Despite being one of the top ten infectious causes of death globally, Strep A continues to receive far too little attention” - Jerome Kim IVI joins health leaders for a #WHA78 side event to mobilize global action on Strep A vaccines. 🔗 Read more: ivi.int/health-leaders…

“Leptospirosis...should no longer remain among the most neglected of the neglected tropical diseases,” said Jerome Kim at #WHA78. IVI and partners hosted an event on global advocacy and policy for this deadly but neglected disease. 🔗 Read more: ivi.int/global-leaders…

An honor to meet with المركز الخليجي للوقاية من الأمراض و مكافحتها and مجلس الصحة الخليجي during #WHA in Geneva. We discussed vaccine R&D, training, and future collaboration. Looking forward to advancing shared goals in global health together.

Dr. Alberto Cagigi will represent IVI at the European Parliament Event on June 10, joining a panel discussion on strategies to tackle vaccine hesitancy. The event is hosted by PATH & Infectious Disease Alliance and organized by MEP Nicolás González Casares Read more: lnkd.in/dYQCuvdA

We are incredibly grateful to the Government of the Philippines for making its third annual voluntary contribution to IVI. Thank you, Ambassador Maria Theresa Dizon-De Vega PHLinKorea for your steadfast support of IVI's mission to accelerate vaccines and build capacity!

🔔 Apply by 5 June 2025! We encourage technicians, engineers, scientists, and managers involved in biomanufacturing to join us for an intensive hands-on training course across vaccine research, development, and manufacturing. Learn more and apply here: ivi.int/call-for-appli…

Congratulations to Dr. Delese Mimi Darko on her appointment as the first Director-General of the African Medicines Agency! As a member of IVI’s Scientific Advisory Group, Dr. Darko brings invaluable insight—and we look forward to continued collaboration with AMA.